Accuracy and Feasibility of Xpert Ultra

CompletedOBSERVATIONAL
Enrollment

1,400

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

October 31, 2017

Conditions
Tuberculosis, Pulmonary
Interventions
DEVICE

Xpert MTB/RIF Ultra

Next generation Xpert MTB/RIF assay, this cartridge is intended for the detection of M. tuberculosis in sputum as well as the detection of M. tuberculosis mutations associated with resistance to rifampin

Trial Locations (6)

Unknown

Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk

Clinical Research Unit, National Center for Tuberculosis and Lung Diseases, Tbilisi

National Institute for Research in Tuberculosis, Madras

Dept of Microbiology, Hinduja Hospital, Mumbai

New Delhi Tuberculosis Centre, New Delhi

Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Science, University of the Witwatersrand, and The National Priority Program of the National Health Laboratory Service, Johannesburg

All Listed Sponsors
lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT03072576 - Accuracy and Feasibility of Xpert Ultra | Biotech Hunter | Biotech Hunter